Canadian Online Dispensaries | Best Weed, Cannabis & Magic Mushrooms

Magic mushrooms, scientifically known as Psilocybe species, have been consumed for their psychoactive effects for centuries. However, the modern wave of psychedelic interest has given rise to a new form of consumption: microdose magic mushroom pills. These capsules offer a precise and convenient way to ingest psilocybin, the active compound in magic mushrooms. But how are these pills produced? Let’s delve into the process. 

Best buy link is here :- https://thirdeyemicrodose.com/product/third-eye-chai-microdosed-high-tea/

Cultivation of Magic Mushrooms: 

The process begins with the cultivation of magic mushrooms. Typically grown in controlled environments, these fungi thrive in moist, dark conditions. A substrate, often a mixture of grains and organic materials, provides the necessary nutrients. Over a few weeks, the mycelium colonizes the substrate, eventually producing fruiting bodies or mushrooms. 

Harvesting and Drying 

Once mature, the mushrooms are harvested. Timing is crucial, as mushrooms are typically picked before their caps fully uncurl. After harvesting, they are dried to preserve their potency. This drying process involves placing them in a dehydrator or airing them out in a well-ventilated space, ensuring they retain their psychoactive properties. 

Extraction of Psilocybin 

To extract psilocybin, the dried mushrooms are first ground into a fine powder. This powdered form ensures a uniform consistency, aiding the subsequent extraction process. The cell walls are broken down by grinding the mushrooms, making the active compounds more accessible. 

This powder then undergoes an extraction process, often involving solvents, to isolate the psilocybin. Careful measures are taken to ensure the purity of the extraction. The result is a concentrated psilocybin extract, free from other mushroom components, providing a potent, unadulterated compound source. 

Determining Dosage 

One of the main benefits of magic mushroom pills is the precision in dosing. Using laboratory equipment, the concentration of psilocybin in the extract is determined. This ensures that each pill contains a consistent and known amount of the active compound, enabling safe and controlled microdosing. 

Encapsulation 

The psilocybin extract is then prepared for encapsulation. It’s mixed with a carrier substance, often a harmless filler, to achieve the desired microdose amount. This mixture is then loaded into gelatin or vegetarian capsules using specialized machinery, ensuring each capsule contains the required dose. 

Quality Control and Packaging 

Before being released to consumers, the pills undergo rigorous quality control checks. This step ensures that each capsule meets the required potency, purity, and safety standards. Once approved, the pills are packaged in airtight containers to preserve their efficacy and shelf life. 

The transformation of magic mushrooms into microdose pills is a meticulous journey that marries traditional cultivation techniques with modern extraction and encapsulation methods. The result is a product that offers the benefits of psilocybin in a precise, convenient, and discreet form. As research continues to shed light on the potential therapeutic uses of psilocybin, these capsules are poised to play a pivotal role in the future of psychedelic wellness. 

References: 

• Stamets, P. (2019). Psilocybin Mushrooms of the World: An Identification Guide. Ten Speed Press. 
• Johnson, M. W., Griffiths, R. R., & Hendricks, P. S. (2018). The abuse potential of medical psilocybin according to the eight factors of the Controlled Substances Act. Neuropharmacology, 142, 143-166. 
• Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264-355. 
• Carhart-Harris, R. L., & Goodwin, G. M. (2017). The therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacology, 42(11), 2105-2113. 
• Brown, R. T., Nicholas, C. R., Cozzi, N. V., Gassman, M. C., Cooper, K. M., Muller, D., … & Hutson, P. R. (2017). Pharmacokinetics of escalating doses of oral psilocybin in healthy adults. Clinical Pharmacokinetics, 56(12), 1543-1554. 
• Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The pharmacology of lysergic acid diethylamide: a review. CNS Neuroscience & Therapeutics, 14(4), 295-314. 
• Polito, V., & Stevenson, R. J. (2019). A systematic study of microdosing psychedelics. PLOS ONE, 14(2), e0211023.